| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Alexander I Bondarenk. Cannabinoids and Cardiovascular System. Advances in experimental medicine and biology. vol 1162. 2019-09-11. PMID:31332735. |
the chapter will first review the effects of marijuana smoking on cardiovascular system and then describe the impact of exogenous cannabinoids on cardiovascular parameters in humans and experimental animals. |
2019-09-11 |
2023-08-13 |
Not clear |
| Vladimiro Cardenia, Tullia Gallina Toschi, Simona Scappini, Rosamaria Cristina Rubino, Maria Teresa Rodriguez-Estrad. Development and validation of a Fast gas chromatography/mass spectrometry method for the determination of cannabinoids in Cannabis sativa L. Journal of food and drug analysis. vol 26. issue 4. 2019-09-06. PMID:30249327. |
development and validation of a fast gas chromatography/mass spectrometry method for the determination of cannabinoids in cannabis sativa l. a routine method for determining cannabinoids in cannabis sativa l. inflorescence, based on fast gas chromatography coupled to mass spectrometry (fast gc/ms), was developed and validated. |
2019-09-06 |
2023-08-13 |
Not clear |
| Vladimiro Cardenia, Tullia Gallina Toschi, Simona Scappini, Rosamaria Cristina Rubino, Maria Teresa Rodriguez-Estrad. Development and validation of a Fast gas chromatography/mass spectrometry method for the determination of cannabinoids in Cannabis sativa L. Journal of food and drug analysis. vol 26. issue 4. 2019-09-06. PMID:30249327. |
in the analyzed samples, the main cannabinoid was cannabidiolic acid (cbda, 5.19 ± 0.58 g/100 g), followed by cannabidiol (cbd, 1.56 ± 0.03 g/100 g) and cbga (0.83 g/100 g). |
2019-09-06 |
2023-08-13 |
Not clear |
| Hudaisa Fatima, Allyn C Howlett, Christopher T Whitlo. Reward, Control & Decision-Making in Cannabis Use Disorder: Insights from Functional MRI. The British journal of radiology. vol 92. issue 1101. 2019-09-05. PMID:31364398. |
the effects of trans-del-ta-9-tetrahydrocannabinol (Δ9-thc) in marijuana and other preparations of cannabis are mediated by the endocannabinoid system, which is also briefly introduced.much variation exists in the current literature regarding the functional changes associated with chronic cannabis use. |
2019-09-05 |
2023-08-13 |
human |
| Pal Pacher, Sabine Steffens, György Haskó, Thomas H Schindler, George Kuno. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nature reviews. Cardiology. vol 15. issue 3. 2019-08-30. PMID:28905873. |
cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. |
2019-08-30 |
2023-08-13 |
Not clear |
| Maya R Jacobson, Jeremy J Watts, Isabelle Boileau, Junchao Tong, Romina Mizrah. A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 29. issue 3. 2019-08-26. PMID:30635160. |
cannabis, the most widely used illicit drug worldwide, produces psychoactive effects through its component cannabinoids, which act on the endocannabinoid system. |
2019-08-26 |
2023-08-13 |
Not clear |
| Maya R Jacobson, Jeremy J Watts, Isabelle Boileau, Junchao Tong, Romina Mizrah. A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 29. issue 3. 2019-08-26. PMID:30635160. |
the most well established finding is the down-regulation of cannabinoid cb1 receptors (cb1r) after chronic and recent cannabis exposure, but it remains uncertain whether this effect is present in cannabis users with schizophrenia. |
2019-08-26 |
2023-08-13 |
Not clear |
| Maya R Jacobson, Jeremy J Watts, Isabelle Boileau, Junchao Tong, Romina Mizrah. A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 29. issue 3. 2019-08-26. PMID:30635160. |
we highlight where cannabis exposure affects the endocannabinoid system in a pattern that may mirror what is seen in psychosis, and how further research can push this field forward. |
2019-08-26 |
2023-08-13 |
Not clear |
| Maya R Jacobson, Jeremy J Watts, Isabelle Boileau, Junchao Tong, Romina Mizrah. A systematic review of phytocannabinoid exposure on the endocannabinoid system: Implications for psychosis. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 29. issue 3. 2019-08-26. PMID:30635160. |
in these times of changing cannabis legislation, research highlighting the biological effects of cannabinoids is greatly needed. |
2019-08-26 |
2023-08-13 |
Not clear |
| b' Josefina Gerlach, Barbara Koret, Natko Gere\\xc5\\xa1, Katarina Mati\\xc4\\x87, Diana Prskalo-\\xc4\\x8cule, Tihana Zadravec Vrbanc, Vanja Lovreti\\xc4\\x87, Katarina Skopljak, Tin Mato\\xc5\\xa1, Ivona \\xc5\\xa0imunovi\\xc4\\x87 Filip\\xc4\\x8di\\xc4\\x87, Igor Filip\\xc4\\x8di\\xc4\\x8. Clinical Challenges in Patients with First Episode Psychosis and Cannabis Use: Mini-Review and a Case Study. Psychiatria Danubina. vol 31. issue Suppl 2. 2019-08-26. PMID:31158117.' |
in clinical practice clinicians treating new onset psychosis need to be watchful for cannabis and synthetic cannabinoids induced psychosis. |
2019-08-26 |
2023-08-13 |
Not clear |
| Emily Brook, John Mamo, Rachel Wong, Hani Al-Salami, Marco Falasca, Virginie Lam, Ryusuke Takech. Blood-brain barrier disturbances in diabetes-associated dementia: Therapeutic potential for cannabinoids. Pharmacological research. vol 141. 2019-08-23. PMID:30616019. |
the two major cannabinoids, cannabidiol and tetrahydrocannabinol, exert anti-inflammatory and vascular protective effects, however few studies report their potential for reversing bbb dysfunction, particularly in t2d. |
2019-08-23 |
2023-08-13 |
Not clear |
| Sara Malaca, Francesco Paolo Busardò, Massimo Gottardi, Simona Pichini, Emilia Marche. Dilute and shoot ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC-MS/MS) analysis of psychoactive drugs in oral fluid. Journal of pharmaceutical and biomedical analysis. vol 170. 2019-08-21. PMID:30904741. |
the target compounds were 6-monoacetylmorphine, morphine, codeine, cocaine, benzoylecgonine, amphetamine, methamphetamine, 3,4-methylenedioxymethamphetamine, Δ-9-tetrahydrocannabinol, cannabidiol, mephedrone, ketamine and synthetic cannabinoid 5f-akb48 (5f-apinaca). |
2019-08-21 |
2023-08-13 |
Not clear |
| Ruth Gallily, Zhannah Yekhti. Avidekel Cannabis extracts and cannabidiol are as efficient as Copaxone in suppressing EAE in SJL/J mice. Inflammopharmacology. vol 27. issue 1. 2019-08-14. PMID:30291491. |
the non-psychotropic immunosuppressive cannabinoid compound cannabidiol (cbd) has recently been shown to have beneficial effects on experimental autoimmune encephalomyelitis (eae). |
2019-08-14 |
2023-08-13 |
mouse |
| Serena Silvestro, Santa Mammana, Eugenio Cavalli, Placido Bramanti, Emanuela Mazzo. Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials. Molecules (Basel, Switzerland). vol 24. issue 8. 2019-08-14. PMID:31013866. |
cannabidiol (cbd) is one of the cannabinoids with non-psychotropic action, extracted from |
2019-08-14 |
2023-08-13 |
Not clear |
| Sebastian Rojek, Małgorzata Korczyńska-Albert, Joanna Kulikowska, Małgorzata Kły. New challenges in toxicology of new psychoactive substances exemplified by fatal cases after UR-144 and UR-144 with pentedrone administration determined by LC-ESI-MS-MS in blood samples. Archiwum medycyny sadowej i kryminologii. vol 67. issue 2. 2019-08-13. PMID:29363897. |
the victims were men aged 16, 22 and 40 years who used drugs, for example they smoked marijuana or its substitutes in the form of synthetic cannabinoids. |
2019-08-13 |
2023-08-13 |
Not clear |
| Angel E Sánchez Artiles, Areeba Awan, Mitchell Karl, Antonello Santin. Cardiovascular effects of cannabis (marijuana): A timely update. Phytotherapy research : PTR. vol 33. issue 5. 2019-08-12. PMID:30761633. |
plants of this species contain many psychoactive components, the cannabinoids, including the primary psychoactive compound Δ-9-tetrahydrocannabinol (thc), the active substance present in marijuana. |
2019-08-12 |
2023-08-13 |
Not clear |
| Alex Mabou Tagne, Franca Marino, Massimiliano Legnaro, Alessandra Luini, Barbara Pacchetti, Marco Cosentin. A Novel Standardized International journal of molecular sciences. vol 20. issue 8. 2019-08-09. PMID:31013912. |
a novel standardized cannabis and cannabinoids offer significant therapeutic benefits for a wide scope of pathological conditions. |
2019-08-09 |
2023-08-13 |
Not clear |
| Tim Ambrose, Alison Simmon. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease? Journal of Crohn's & colitis. vol 13. issue 4. 2019-08-05. PMID:30418525. |
cannabis, cannabinoids, and the endocannabinoid system-is there therapeutic potential for inflammatory bowel disease? |
2019-08-05 |
2023-08-13 |
human |
| Tim Ambrose, Alison Simmon. Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease? Journal of Crohn's & colitis. vol 13. issue 4. 2019-08-05. PMID:30418525. |
there is accumulating evidence that exogenous cannabis and related cannabinoids improve symptoms associated with inflammatory bowel disease [ibd], such as pain, loss of appetite, and diarrhoea. |
2019-08-05 |
2023-08-13 |
human |
| Ann E Klega, Jennifer Tickal Keehbauc. Stimulant and Designer Drug Use: Primary Care Management. American family physician. vol 98. issue 2. 2019-08-01. PMID:30215997. |
synthetic cannabinoids can have a more intense and long-lasting effect than natural cannabis. |
2019-08-01 |
2023-08-13 |
Not clear |